Skip to main content
. 2018 Nov 27;9(6):598–606. doi: 10.1177/2192568218814235

Table 7.

Characteristic Comparison Between Patients Requiring Prolonged Opioid Use (>1 Year) After Fusion and Patients Without Prolonged Opioid Use, n (%).

Characteristic Patients With Prolonged (>1 Year) Opioid Use After Fusion Patients Without Prolonged Opioid Use After Fusion P
Total patients 8740 4517 n/a
 Male 3458 (39.6) 1928 (42.7) <.001
 Female 5282 (60.4) 2589 (57.3)
 Average LOS (days) 8.05 (SD = 7.9) 7.62 (SD = 6.4) <.001
Geographical region breakdown
 Midwest 2002 (22.9) 1220 (27.0) <.0001
 Northeast 159 (1.8) 117 (2.6)
 South 5649 (64.6) 2712 (60.0)
 West 930 (10.6) 468 (10.4)
Race breakdown
 Unknown 728 (8.3) 574 (12.7) <.0001
 White 7149 (81.8) 3578 (79.2)
 Black 673 (7.7) 253 (5.6)
 Other 64 (0.7) 43 (1.0)
 Asian 19 (0.2) 14 (0.3)
 Hispanic 86 (1.0) 46 (1.0)
 North American Native 21 (0.2) 9 (0.2)
Preoperative comorbidities
 Obesity (BMI >30 kg/m2) 2145 (24.5) 918 (20.3) <.0001
 Any opioid use 6 months prior to fusion 5982 (68.4) 1674 (37.1) <.05
 Smoker 1778 (20.3) 517 (11.4) <.05
 Type 2 diabetes mellitus 3236 (37.0) 1587 (35.1) <.05

Abbreviations: BMI, body mass index; LOS, length of stay; n/a, not applicable; SD, standard deviation.